KTR hits out at Revanth Reddy for deceiving farmers on Pharma City development

Hyderabad: BRS working president K T Rama Rao accused the Congress government of deceiving farmers and tribal communities who gave up their lands for the development of the Hyderabad Pharma City project. He said Chief Minister A Revanth Reddy, who promised to return the Pharma City lands to farmers, was now planning to build the Future City and conspiring to turn fertile lands into real estate goldmines for his family and friends.

Rama Rao said Revanth Reddy’s wrongdoings were piling up, from attempting to plunder Dalit and tribal lands in Kodangal for his son-in-law’s pharma venture to diverting Pharma City lands for the Future City, to benefit the Anumula brothers. He slammed the Congress for its U-turn on Pharma City.

“Revanth Reddy had promised to scrap the project and return lands to farmers. But instead, his government is now trying to divert the same lands for shady deals. This is fraud at its worst,” he declared.

The BRS working president also condemned the government’s conflicting stance on the Pharma City, where it had publicly announced the project’s cancellation but submitted affidavits in court stating that it was under implementation. “This is not just betrayal of farmers, it is contempt of court,” he said.

He demanded that the Congress government explain why the lands were not being returned as promised during the elections, or why no efforts were being made to engage in discussions with the agitating farmers to resolve the issue.

Rama Rao stated that the ruling party had built its governance on “fake promises, legal manipulation, official harassment, and shameless land grabbing.” He asserted that the Pharma City lands cannot be used for other purposes and warned that farmers are in no mood to forgive the Congress government if the lands are not returned. He cautioned that if the Congress proceeds with land allocations under the Future City banner, BRS will join hands with aggrieved farmers and launch a serious agitation.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert